KPET Ultra Paceline Corp 8-K

What Happened

• KPET Ultra Paceline Corporation announced that its registration statement was declared effective on March 30, 2026 and that it consummated its IPO on April 1, 2026, selling 20,000,000 units at $10.00 per unit. Each Unit consists of one Class A ordinary share and one‑sixth of one warrant; each full Warrant allows the holder to buy one Class A share at $11.50.
• In connection with the IPO the company entered into standard SPAC agreements (underwriting agreement with Deutsche Bank Securities Inc., warrant and trust agreements with Continental Stock Transfer & Trust Company, registration rights, administrative support, private placement purchase agreement, indemnities, and a letter agreement with officers/directors and sponsors).
• Of the net proceeds, $200,000,000 (which includes $11,000,000 of deferred underwriting discounts and commissions) has been deposited in a U.S.-based trust account. The trust funds generally cannot be released except to complete an initial business combination, to satisfy certain redemption rights, or under limited interest-release rules for working capital (up to $500,000 of interest per year).

Key Details

• IPO: 20,000,000 units at $10.00 each (closing April 1, 2026).
• Private placement: 235,000 units sold to the Unit Holder Sponsor at $10.00 each, raising $2,350,000 (issued under Section 4(a)(2) exemption); these Private Placement Units are restricted from transfer until 30 days after an initial business combination (with limited permitted transferees).
• Warrants: each whole Warrant exercisable to buy one Class A share at $11.50. Each Unit included one‑sixth of a Warrant.
• Board changes: Kneeland Youngblood, Kathleen Philips and James McKee were appointed independent directors (all on the Audit Committee; Ms. Philips is Audit Chair; all on the Compensation Committee with Mr. Youngblood as Chair). Each purchased 40,000 Class B shares at original issue price; the Sponsor forfeited 120,000 Class B shares back to the company.

Why It Matters

• For investors, the filing confirms the SPAC has completed its IPO and has substantial cash ($200M) held in trust to pursue an initial business combination. The trust structure means public investors’ funds are protected until a deal is completed or the SPAC winds up (subject to redemption rights and limited interest releases).
• Director appointments and related agreements establish governance and certain shareholder rights (registration rights, transfer restrictions on sponsor/private units), which can affect timing and structure of the future business combination and potential dilution (warrants) for public shareholders.